AETERNUM HEALTH, INC.

AETNdata completeness 75%17 fiscal years on file

Data notes: no data for concept 'capex'; no data for concept 'totalDebt'; no data for concept 'pretaxIncome'

i. The business — what you’d actually own
FigureFY 2023FY 2023FY 2024FY 2024FY 2025
Revenue$22,2811$20,1092$19,6101$65,1213$203,6553
Net income−$315,5244−$632,9485−$661,9654−$450,3186−$337,0946
Operating cash flow−$303,3327−$267,0348−$341,6077−$154,0469−$2,9589
Capital expenditure
Free cash flow (derived)
Total debt
Cash & equivalents$010$011$010$012$012
Diluted shares47.1M42.5M48.1M48.5M49.0M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0.41
your share of equity
Profit it earned you last year
−$0.07
Free cash flow it threw off
Debt you’d be carrying

10 shares is a claim on −$0.41 of net worth that earned you −$0.07 last year.

iii. Is this a good business?
Moat signal · return on equity
avg · 5y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
+4% shares · 5y

Share count is up 4% over 5 years — owners have been diluted. Worth asking what they got for it.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2023-02-28 · accession 0001493152-24-023724 (RevenueFromContractWithCustomerExcludingAssessedTax)
  2. 10-K/A · period ending 2023-12-31 · accession 0001641172-25-026345 (RevenueFromContractWithCustomerExcludingAssessedTax)
  3. 10-K · period ending 2024-12-31 · accession 0001493152-26-014008 (RevenueFromContractWithCustomerExcludingAssessedTax)
  4. 10-K · period ending 2023-02-28 · accession 0001493152-24-023724 (NetIncomeLoss)
  5. 10-K/A · period ending 2023-12-31 · accession 0001641172-25-026345 (NetIncomeLoss)
  6. 10-K · period ending 2024-12-31 · accession 0001493152-26-014008 (NetIncomeLoss)
  7. 10-K · period ending 2023-02-28 · accession 0001493152-24-023724 (NetCashProvidedByUsedInOperatingActivities)
  8. 10-K/A · period ending 2023-12-31 · accession 0001641172-25-026345 (NetCashProvidedByUsedInOperatingActivities)
  9. 10-K · period ending 2024-12-31 · accession 0001493152-26-014008 (NetCashProvidedByUsedInOperatingActivities)
  10. 10-K · period ending 2023-02-28 · accession 0001493152-24-023724 (CashAndCashEquivalentsAtCarryingValue)
  11. 10-K/A · period ending 2023-12-31 · accession 0001641172-25-026345 (CashAndCashEquivalentsAtCarryingValue)
  12. 10-K · period ending 2024-12-31 · accession 0001493152-26-014008 (CashAndCashEquivalentsAtCarryingValue)